Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | PXS-5505 |
| Trade Name | |
| Synonyms | PXS 5505|PXS5505 |
| Drug Descriptions |
PXS-5505 inhibits lysyl oxidases, potentially leading to reduced tumor growth (HPB (2021) 23: S493-S494). |
| DrugClasses | |
| CAS Registry Number | 2409963-83-1 |
| NCIT ID | C179584 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Atezolizumab + Bevacizumab + PXS-5505 | Atezolizumab Bevacizumab PXS-5505 | 0 | 1 |
| PXS-5505 | PXS-5505 | 0 | 1 |